Clinical Research
person

José Antonio G. D.

Country
Spain
Department
Medicina Interna

Research Overview

assignment
4
Clinical Trials ·
location_city
1
Research Sites

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
81
Sites with multiple studies

Has run more than one trial at 81 of 537 partner sites.

Specializations

Oncology

Clinical research activity includes breast cancer, non-small cell lung cancer, renal cell carcinoma, urothelial carcinoma, and prostate cancer, with additional involvement in ovarian cancer, gastric cancer, colorectal cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma. The portfolio also extends to sarcoma, thyroid cancer, bladder cancer, and other solid tumors.

  • Metastatic and advanced solid tumors
  • Breast cancer subtypes
  • Genitourinary cancers
  • Thoracic and gastrointestinal malignancies

Research interests in this area reflect a strong therapeutic focus on systemic treatment options for difficult-to-treat cancers, including biomarker-defined disease and recurrent or unresectable malignancies.

Cardiovascular and renal medicine

Investigator involvement covers atherosclerotic cardiovascular disease, acute coronary syndrome, myocardial infarction, heart failure, atrial fibrillation, hypertension, and stroke prevention. Renal interests include chronic kidney disease, IgA nephropathy, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, and complement-mediated kidney disease.

  • Cardiovascular risk reduction
  • Resistant hypertension
  • Glomerular disease
  • Renal protection in chronic disease

This area also includes therapeutic work on cardiometabolic risk and kidney-related complications in patients with complex systemic disease.

Neurology and neuropsychiatry

Clinical trial involvement includes multiple sclerosis, epilepsy, migraine, Alzheimer’s disease, Parkinson’s disease, schizophrenia, and bipolar depression. Additional interest is seen in psychosis associated with Alzheimer’s disease, cognitive impairment, and refractory status epilepticus.

  • Seizure disorders
  • Neurodegenerative disease
  • Psychiatric symptoms
  • Headache disorders

The therapeutic landscape also includes conditions affecting cognition, behavior, and disability progression in chronic neurological disease.

Autoimmune, inflammatory, and respiratory disorders

Research activity spans systemic lupus erythematosus, lupus nephritis, systemic sclerosis-associated interstitial lung disease, atopic dermatitis, psoriasis, chronic spontaneous urticaria, and thyroid eye disease. Respiratory interests include idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, asthma, community-acquired pneumonia, and respiratory syncytial virus infection.

  • Immune-mediated skin disease
  • Systemic autoimmune disease
  • Fibrotic lung disease
  • Inflammatory airway disease

These interests align with therapeutic development in chronic inflammatory conditions and immune-driven organ involvement.

Ophthalmology, infectious disease, and metabolic conditions

Additional clinical interests include dry eye disease, glaucoma, diabetic retinopathy, and neovascular age-related macular degeneration. The investigator is also involved in studies of COVID-19, HIV infection, urinary tract infections, and vaccination-related infection prevention, alongside metabolic conditions such as obesity and dyslipidemia.

  • Retinal and ocular surface disease
  • Viral and bacterial infections
  • Metabolic risk states
  • Preventive cardiometabolic therapy

These topics show engagement with therapeutic areas that connect chronic disease management, infection control, and sensory health.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.